KRISTINA MULLEN: Open Payments
NPI 1124505706 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 32 payments from 10 companies in 2025. Trend: 2023 $2,234 · 2024 $1,883 · 2025 $751
Food & beverage: $751
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $272 |
| Neurocrine BioSciences, Inc. | 3 | $174 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 2 | $36 |
| Lundbeck LLC | 1 | $34 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Almatica Pharma LLC | 1 | $15 |
Products named: VRAYLAR, INGREZZA, REXULTI, TRINTELLIX, CAPLYTA, FANAPT, COBENFY, AUSTEDO XR.
Industry payments across NC — which companies pay providers there.
